Clinical and pharmacokinetic phase II study of pegylated liposomal doxorubicin and vinorelbine in heavily pretreated recurrent ovarian carcinoma
D Katsaros(Gynecologic Oncology Group), C. Bumma(Ospedale San Giovanni Antica Sede), S. Fracchioli(Gynecologic Oncology Group), Michela Donadio(Azienda Ospedaliero Universitaria San Giovanni Battista), Maria Vittoria Oletti(Ospedale San Giovanni Antica Sede), Luigi Cattel(University of Turin), A Celano(Ospedale San Giovanni Antica Sede), Irene A. Rigault de la Longrais(Gynecologic Oncology Group), Roberto Passera(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Annamaria Ferrero
Cited by 25
Related Papers
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
|Annals of Oncology|2019|1.2k